It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Chlamydia pneumoniae is a respiratory tract pathogen but can also infect the central nervous system (CNS). Recently, the link between C. pneumoniae CNS infection and late-onset dementia has become increasingly evident. In mice, CNS infection has been shown to occur weeks to months after intranasal inoculation. By isolating live C. pneumoniae from tissues and using immunohistochemistry, we show that C. pneumoniae can infect the olfactory and trigeminal nerves, olfactory bulb and brain within 72 h in mice. C. pneumoniae infection also resulted in dysregulation of key pathways involved in Alzheimer’s disease pathogenesis at 7 and 28 days after inoculation. Interestingly, amyloid beta accumulations were also detected adjacent to the C. pneumoniae inclusions in the olfactory system. Furthermore, injury to the nasal epithelium resulted in increased peripheral nerve and olfactory bulb infection, but did not alter general CNS infection. In vitro, C. pneumoniae was able to infect peripheral nerve and CNS glia. In summary, the nerves extending between the nasal cavity and the brain constitute invasion paths by which C. pneumoniae can rapidly invade the CNS likely by surviving in glia and leading to Aβ deposition.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Griffith University, Gold Coast campus, Menzies Health Institute Queensland, Southport, Australia (GRID:grid.1022.1) (ISNI:0000 0004 0437 5432)
2 King’s College London, School of Immunology and Microbial Sciences, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
3 Queensland University of Technology, Centre for Immunology and Infection Control, School of Biomedical Sciences, Brisbane, Australia (GRID:grid.1024.7) (ISNI:0000000089150953)
4 Griffith University, Gold Coast campus, Menzies Health Institute Queensland, Southport, Australia (GRID:grid.1022.1) (ISNI:0000 0004 0437 5432); Griffith University, Nathan campus, Griffith Institute for Drug Discovery, Brisbane Queensland, Australia (GRID:grid.1022.1) (ISNI:0000 0004 0437 5432)